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Abstract
Background: The mechanism by which megakaryocytes (Mks) proliferate, differentiate, and release platelets into circulation
are not well understood. Growing evidence indicates that a complex regulatory mechanism, involving cellular interactions,
composition of the extracellular matrix and physical parameters such as oxygen tension, may contribute to the quiescent or
permissive microenvironment related to Mk differentiation and maturation within the bone marrow.
Methodology/Principal Findings: Differentiating human mesenchymal stem cells (hMSCs) into osteoblasts (hOSTs), we
established an in vitro model for the osteoblastic niche. We demonstrated for the first time that the combination of HSCs,
Mks and hypoxia sustain and promote bone formation by increasing type I collagen release from hOSTs and enhancing its
fibrillar organization, as revealed by second harmonic generation microscopy. Through co-culture, we demonstrated that
direct cell-cell contact modulates Mk maturation and differentiation. In particular we showed that low oxygen tension and
direct interaction of hematopoietic stem cells (HSCs) with hOSTs inhibits Mk maturation and proplatelet formation (PPF).
This regulatory mechanism was dependent on the fibrillar structure of type I collagen released by hOSTs and on the
resulting engagement of the alpha2beta1 integrin. In contrast, normoxic conditions and the direct interaction of HSCs with
undifferentiated hMSCs promoted Mk maturation and PPF, through a mechanism involving the VCAM-1 pathway.
Conclusions/Significance: By combining cellular, physical and biochemical parameters, we mimicked an in vitro model of
the osteoblastic niche that provides a physiological quiescent microenvironment where Mk differentiation and PPF are
prevented. These findings serve as an important step in developing suitable in vitro systems to use for the study and
manipulation of Mk differentiation and maturation in both normal and diseased states.
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Introduction
Hemopoiesis occurs in a complex microenvironment within the
bone marrow. Megakaryocytes (Mks) and their progeny, circulat-
ing anucleated platelets (plts), are vascular cells involved in many
aspects of hemostatic and inflammatory functions, as well as the
site for many blood disorders. As observed in mice, Mks release
platelets through a complex mechanism that converts the bulk of
their cytoplasm into multiple long processes called proplatelets
[1,2]. These protrusions are thin and branch repeatedly. Mk
maturation and platelet generation occurs in selected environ-
ments within the bone marrow, with proplatelet formation
following Mk migration from the osteoblastic to the vascular
niche, where newly generated platelets can be released into the
bloodstream [3].
A growing body of evidence indicates that the characteristics of
the microenvironment surrounding Mks plays an important role in
the regulation of platelet production within the bone marrow
[4,5,6]. The vascular niche is comprised of extracellular matrix
(ECM) proteins such as collagen type IV, fibronectin, laminin,
fibrinogen [7,8], and most likely VWF, which allow proplatelet
formation. Type I collagen, however, completely suppresses
proplatelet formation and is the most abundant extracellular
protein of the osteoblastic niche [7,9]. It is known that mutual
regulatory interactions occur between Mks and osteoblasts, with
Mks contributing to bone homeostasis and osteoblasts supporting
megakaryopoiesis through the release of growth factors [10,11].
However, it is also known that under normal physiological
conditions the osteoblastic niche inhibits Mk maturation and
differentiation [12,13,14]. Therefore, the dynamic interaction of
Mks with the different ECM proteins within the bone marrow
seems to orchestrate their maturation in specific sites. In addition,
we have shown that engagement of receptors is dependent on both
the composition and structural properties of these matrices [6,15].
Underlying these complex regulatory mechanisms is the
development of mechanical forces and the activation of biochem-
ical signaling pathways, which may be modulated by biophysical
signaling. Oxygen tension, for example, is a modulator of cell
activity within the bone marrow, and an oxygen gradient exists
between the osteoblastic and vascular niches [16], with more
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compartment of the bone marrow [17,18]. On this basis, it is clear
that a variety of different features contribute to the formation of a
quiescent or permissive microenvironment for hemopoietic stem
cell differentiation and maturation within the bone marrow space,
necessitating a more complex in vitro model. Although the
development of in vitro culture techniques has greatly improved
our knowledge of blood cell production, several aspects of
hemopoiesis remain unresolved due to the inability of current in
vitro models to reproduce the complexity of the bone marrow.
The purpose of this study was to establish an in vitro model for
Mk function in the bone niche environment. First we formed a
model that reproduced and combined most cellular, matrix, and
physical components that characterize the physiological osteoblas-
tic niche. Further, by including hemopoietic stem cells (HSCs) in
the model, we investigated crosstalk between HSCs and cells
comprising the osteoblastic niche. This work represents the first
step towards the development of a new 3D bone marrow model
for understanding basic cell biology and regulatory mechanisms of
platelet formation. The long term goal is to utilize this type of
model to elucidate new clinical options to control these cells for
disease management.
Results
In vitro reproduction of osteoblastic niche physiological
environment
To develop a physiological osteoblastic niche to study
hemopoiesis, human mesenchymal stem cells (hMSCs) were
differentiated towards the osteoblastic (hOST) lineage for six
days, corresponding to the upregulation of the bone-related genes:
bone sialoprotein (BSP), alkaline phosphatase (ALP) and type I
collagen (Figure 1A–C). In addition, a time course analysis
revealed that type I collagen expression by hOSTs peaked after
eleven days of differentiation and rapidly decreased afterwards
(Figure 1C). These results were also confirmed at the protein level
by dot blot analysis that revealed type I collagen only in hOSTs
after 11 days of culture (Figure 1D). Consistently, type I collagen
was progressively released by hOSTs with a peak after fourteen
days of culture, as revealed by hydroxyproline assay (Figure 1E).
Finally, in Figure 1F we show that only hOSTs, and not hMSCs,
presented calcium depositions over time.
In order to recapitulate the relationship between Mk and
osteoblast differentiation and maturation [19], co-culture exper-
iments were performed. Human umbilical cord blood (hUCB)
derived progenitor cells were cultured on hOSTs at day 6 of
differentiation, with co-cultures maintained for twelve days in the
presence of growth factors specific for progenitor differentiation
towards the megakaryocytic lineage. While Mks were differenti-
ating and maturing (Figure 2A), a progressive increase in type I
collagen release was observed as revealed by hydroxyproline
quantification (Figure 2B). Interestingly, when co-cultures were
maintained in hypoxic conditions, the concentrations observed at
each time point were significantly higher than those reported for
hOST cultures alone or co-cultures at normoxic conditions
(Figure 2B). As expected, these results indicate that hemopoietic
progenitors and Mks promote and sustain bone formation and
matrix deposition. Likewise, oxygen tension also plays a crucial
role in promoting type I collagen release.
We further investigated the deposition of type I collagen with
second harmonic generation (SHG) imaging, a non-invasive
optical method that exploits non-linear light scattering from
fibrillar collagen. Using this technology, a time course analysis of
the deposition of fibrillar type I collagen from hOSTs revealed
that, hOSTs in co-culture with HSCs at 5% oxygen tension
organized regularly oriented collagen fibers. These fibers were
evident after eleven days of culture, with the presence of aligned
fibers increasing progressively until day 18 of culture when fibrils
were so abundant that they totally covered the underlying
osteoblastic layer (Figure 2C). To exclude the possibility that
SHG images were derived from the presence of other fibrillar
collagen types produced by hOSTs, we analyzed the expression of
type II and III collagens and these were negative at day 6 of
differentiation (Figure 2D) and did not increase thereafter (data
not shown). Further type II and III collagen expression was absent
during the culture of osteoblasts alone and hOST-HSC cocultures
at both oxygen tensions (data not shown). Therefore, since hOSTs
are known to express only type I, II and III collagens, we conclude
that both the SHG images and hydroxyproline assays were derived
from type I collagen only.
Influence of hMSCs and hOSTs on HSC and Mk
development
The role of the osteoblastic niche in regulating HSC
proliferation, differentiation and maturation was investigated by
adding HSCs to the model system. CD34
+ cells were plated on a
confluent monolayer of hMSCs or hOSTs at day 6 of
differentiation as reported above, and cultured in the presence
of thrombopoietin for twelve additional days. Controls were
performed by plating CD34
+ cells in suspension cultures,
supplemented with the same media and growth factors. In our
system when HSCs were cultured with adhesion to either hMSCs
or hOSTs, cell proliferation was not affected with respect to
controls (Figure 3A). These data point to the fundamental
regulatory role of the physical interactions between HSCs and
their microenvironment in the regulation of hemopoiesis.
Moreover the effects of different co-culture environments on Mk
differentiation and maturation were examined over time. Co-
cultures of HSCs with both hMSCs and hOSTs over a 12-day
culture resulted in sustained Mk differentiation and no significant
differences in Mk outputs (Figure 3B). However, Mk maturation
stage classification, according to standard criteria [20], revealed
significant differences in the maturation profiles between HSC-
hMSC and HSC-hOST co-cultures (Figure 3B), indicating that
hMSCs did not influence differentiation, but rather maturation of
Mks. To clarify the Table in Figure 3B, we included a
representative image of CD61
+ cells at different stages of
maturation from which counts were made (Figure 3C). In order
to study complete maturation of Mks we analyzed proplatelet
formation (PPF) and we found that Mks, differentiated in adhesion
to hMSCs, extended a significantly higher number of proplatelets
when compared to control (Figure 3D). Interestingly hypoxia
completely suppressed this effect (Figure 3D). Further hypoxia
determined a significant decrease of PPF on hOSTs demonstrating
that, in this in vitro model of osteoblastic niche, cellular and
physical parameters combine to inhibit HSC maturation within
the osteoblastic niche (Figure 3D).
Role of integrins alpha2beta1 and VLA-4 on
megakaryopoiesis
Since it was shown that in normoxic conditions, adhesion of
Mks to endothelial cells promotes PPF through a mechanism
mediated by VCAM-1 [3], we investigated the same pathway in
our system. hMSCs, and not differentiated hOSTs, constitutively
expressed vascular cell adhesion molecule 1 (VCAM-1) that was
also revealed on the membrane surface by cytofluorimetric
analysis. Interestingly, as already demonstrated by others
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PLoS ONE | www.plosone.org 2 December 2009 | Volume 4 | Issue 12 | e8359[21,22], in our system hypoxia also inhibited VCAM-1 expression
in hMSCs, demonstrating a significant decrease in VCAM-1
expression at each time point of culture at 5% oxygen tension
when compared to those performed at 20% oxygen tension (data
not shown). On this basis, to further investigate the regulation of
Mk differentiation and maturation by contact with hMSCs and
hOSTs [23], mature Mks were plated on confluent layers of
hMSCs in the presence of unrelated IgG or monoclonal antibody
P1H4 anti-integrin VLA-4, or on confluent layers of hOSTs, on
differentiation day 18, in the presence of unrelated IgG or
monoclonal antibody P1E6 anti-integrin alpha2beta1. In each
case, suspension cultures were used as controls. In terms of cell
attachment, when Mks were plated on hMSCs, the presence of
anti-VLA-4 did not alter adhesion, while there was a reduction of
about 30% in Mk adhesion in the presence of the anti-alpha2
antibody on hOSTs (Figure 4A). Further, as shown in Figure 4B,
upon incubation with VLA-4 antagonist, PPF was significantly
decreased. These results indicate that alpha(4)beta(1) integrin
(VLA-4) and its ligand VCAM-1 axis play a central role in
promoting PPF by mature Mks co-cultured with hMSCs.
In parallel experiments we demonstrated the ability of anti-
alpha2 antibody to relieve PPF inhibition by hOSTs (Figure 4B).
The integrin involvement in the mechanisms described seemed to
be consistent with the type of co-culture: in fact no changes were
Figure 1. Characterization of the osteoblastic niche. As markers of differentiation we analyzed the expression of bone-related genes, BSP (A),
ALP (B) and type I collagen (C) by hOSTs after 6 days of differentiation, as compared to hMSCs, evaluated by real-time RT-PCR. Error bars represent
standard deviations. (C) Time course analysis of type I collagen expression by hMSCs and hOSTs at different culture time, evaluated by real-time RT-
PCR. (D) Type I collagen protein expression by hMSCs and hOSTs at day 11 of culture. 10 mg of hMSCs and hOSTs lysate and 40 ng of purified type I
collagen (C
+) were employed in a dot-blot assay. (E) Time course analysis of type I collagen release by hMSCs and hOSTs. The amount of
hydroxyproline was measured and then multiplied by a factor of 7.46 to give the total collagen for each well, as described in Materials and Methods.
(F) Mineralization of hMSCs (I, II, III) and hOSTs (IV, V, VI)) was evaluated by alizarin red staining, after 6, 11 and 18 days of differentiation (scale
bar =200 mm). The cultures were performed in normoxic conditions, data are the mean 6 SD of the results obtained in three different experiments
for each sample. *p,0.05.
doi:10.1371/journal.pone.0008359.g001
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alpha2 antibody or hOST-HSC co-culture with anti-VLA-4 (data
not shown).
Previous investigations of the signaling cascades associated with
regulation of PPF by type I collagen via integrin alpha2beta1
revealed the involvement of the Rho/ROCK pathway [24]. As
ROCK is involved in the phosphorylation of the myosin light
chain, this suggests that the actin-myosin cytoskeleton, specifically
the ATPase activity of myosin-IIA, plays a role in the regulation of
PPF. To confirm this, co-cultures of Mks were treated with the
selective antagonist of myosin IIA ATPase activity blebbistatin, in
the physiological environment of 5% oxygen tension. As shown in
Figure 4C, the percentage of PPF generated by blebbistatin-
treated Mks in co-culture with hOSTs was significantly higher
than when these cells were treated with DMSO alone. These data
further confirm the essential role of integrin alpha2beta 1 in PPF
inhibition within the model of the osteoblastic niche.
All together these results indicate that the osteoblastic niche
represents a dynamic space where hMSCs differentiated into
hOSTs physically interact with HSCs and provide a quiescent
environment, while surrounding undifferentiated hMSCs might
support HSC differentiation towards the megakaryocytic lineage.
Furthermore, in this system hypoxia represents one of the key
elements in the inhibition of HSC differentiation by promoting
bone formation while inhibiting the expression of hMSC adhesion
molecules.
Morphological analysis of proplatelets
Analysis of cell morphology by phase contrast microscopy
revealed clear differences in the general architecture of the
proplatelets extended by Mks adherent to hOSTs as compared to
both control cultures and Mks adherent to hMSCs. Immunoflu-
orescence analysis of CD61 staining revealed the presence of self-
wrapped proplatelets [25,26] derived from hOST co-cultures
(Figure 5C) with respect to controls (Figure 5A) and hMSC co-
cultures (Figure 5B) that displayed normal, long extended
proplatelets. In almost 90% of the PPF from hOST co-cultures,
proplatelet shafts appeared wrapped and with a reduced number
of branches. In addition, proplatelet tips did not exhibit their
typical round shape and swellings were not evident at the end of
the proplatelet shaft as seen in controls and hMSC co-cultures
[25,26]. These results provide morphological support for the
regulatory mechanisms that govern platelet maturation and release
within the osteblastic niche.
Discussion
The development of the present model to systematically study
the functional interactions between HSCs and their niche, mimics
and combines in vitro the biochemical and physical parameters of
the osteoblastic niche. By including a new non-linear imaging
approach based entirely on endogenous sources of optical contrast,
this system allows for the non-invasive and dynamic characteriza-
tion of key structural and architectural features of the model
[27,28]. To date, proplatelet formation and platelet release have
been visualized by multiphoton intravital microscopy in intact
bone marrow (BM) [29] and HSC homing and proliferation
within the bone marrow have been traced through the
development of ex-vivo real time imaging technology [30]. These
studies have described the osteoblastic niche as a very dynamic
environment where HSCs can be exposed to both endosteum and
vascular signals that differently determine their fate. Despite this
improvement in the knowledge of functional bone marrow niches,
the mechanisms underlying the relationships between HSCs and
Figure 2. Contribution of HSCs, Mks and hypoxia on type I
collagen release and organization. (A) HSC differentiation into Mks
was monitored over time and % of CD61
+ are reported for each time point.
(B) Collagen produced by hOSTs alone or in direct co-culture with HSCs, at
different oxygen tensions. The amount of hydroxyproline for each well was
evaluated at the indicated time points and converted to collagen, as
described in Materials and Methods. Data are the mean 6 SD of the results
obtained in three different experiments for each sample. (C) Second
harmonic generation images of hOSTs at day 6, day 11, day 14, and 18
alone or in directco-culture with HSCs, performedatO220%oratO25%. All
images were acquired through a 63x (1.2 NA) objective (scale bar =30 mm).
(D) Expression of type II and III collagen by hOSTs after 6 days of
differentiation, as compared to hMSCs, evaluated by real-time RT-PCR.
doi:10.1371/journal.pone.0008359.g002
In Vitro Megakaryopoiesis
PLoS ONE | www.plosone.org 4 December 2009 | Volume 4 | Issue 12 | e8359their environment are not understood, especially in humans where
invasive approaches are not possible. In this context, the ability to
develop and utilize an in vitro model to account for the influences of
bone marrow microenvironments is essential to elucidating the
process involved in cell maturation, migration and function.
The present work demonstrates that HSCs differentiating in
Mks and hypoxia promote not only hMSC differentiation towards
the osteoblastic lineage, but also enhances fibrillar organization of
type I collagen released from hOSTs, demonstrating for the first
time that cellular and physical parameters are fundamental for
both composition and structure of the osteoblastic niche
[31,32,33]. Importantly, by SHG-based imaging, an increase in
type I collagen fibril deposition was observed when HSCs were
added to the system under hypoxic conditions, with regularly
ordered fibrils filling the well by the end of co-culture. These
results clearly demonstrated that the combination of lower oxygen
tension and HSCs formed a niche favorable to fibrillar type I
collagen deposition. Thus, this environment constituted a
quiescent site for HSCs for differentiation through the megakar-
yocytic lineage, but not to complete maturation and extension of
proplatelets, even in the presence of growth factors. These results
are consistent with a model in which the coexistence of hypoxia,
HSCs and Mks promotes type I collagen deposition in the
osteoblastic niche and thus restrains Mks from extending
proplatelets and prevents the premature release of platelets.
Moreover, this model demonstrated that PPF inhibition by type I
collagen depended on its structural properties, as detected by
SHG-based imaging. To support these findings, recent work has
shown that Mk adhesion to collagen type IV, an ECM protein
located around the marrow vessels, supports PPF. Overall, the
mechanisms for the differential effects of collagen subtypes on PPF
are still unknown, but preliminary evidence indicates that these
differences may be ascribed to the distinctive structural properties
of the collagens [6,15].
The inhibitory effect of type I collagen on PPF is mediated by
the interaction with integrin alpha2beta1 [13,34]. Using a specific
antibody to block integrin alpha2beta1, Mk adhesion to hOSTs
was reduced, but their ability to extend propletelets was restored,
eliminating the inhibitory effect induced by the binding of released
type I collagen to its adhesive receptor on the Mk membrane.
Previous work found that the inhibitory action of type I collagen
on PPF is dependent on myosin IIA [6], the only isoform
expressed in Mks and platelets [35] and is encoded by the MYH9
gene, whose mutations cause thrombocytopenia [36]. Two recent
reports have implicated myosin IIA in the Rho/ROCK-mediated
inhibition of PPF [24,37]. The results presented here support these
Figure 3. Role of the osteoblastic niche in megakaryocyte differentiation and proplatelet formation. (A) HSCs were plated in direct co-
culture with hMSCs, or hOSTs or without any feeder layers (control). Adherent cells were counted as described in methods and normalized to relative
control suspension cultures. (B) At day 12 of a direct co-culture cells were stained and the percentage of CD61-positive cells was determined upon
conventional fluorescence microscopy analysis. Mks were assigned to distinct stages of differentiation as described in Materials and Methods. (C)
Representative picture of CD61
+ cells at different stage of maturation. (D) Proplatelet-bearing Mks were then evaluated by fluorescence microscopy,
after staining with anti-alpha tubulin. Results are expressed as percentage of adherent megakaryocytes forming proplatelets and normalized to
relative controls at different oxygen tensions. Data are the mean 6 SD of the results obtained in three different experiments for each sample.
Statistical analysis by one-way ANOVA followed by Bonferroni’s t-test was performed for unpaired observations between hMSCs and hOSTs values.
Student t-test was performed for paired observations to relative control. *p,0.05.
doi:10.1371/journal.pone.0008359.g003
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demonstrating that inhibition of myosin IIA counteracts the ability
of type I collagen to repress PPF in a physiological setting of the
osteoblastic niche. Together, these results indicate that type I
collagen can negatively control PPF as long as the functionality of
myosin is preserved. Interestingly, previous work in the lab showed
that megakaryocytes obtained from the peripheral blood of
patients with specific MYH9 mutations present a loss of function
of myosin-IIA and completely lose the physiologic suppression of
PPF exerted by type I collagen [26]. Finally, as it is known that
hOSTs produce several cytokines that are critical for hemopoiesis
and megakaryopoiesis, this work extends these observations by
demonstrating that physical contact between the osteoblastic niche
environment and Mks can inhibit PPF that is otherwise enhanced
when interactions between HSCs and their environment are
missing [38]. These results strongly support the conclusion that
different elements combine to regulate Mk maturation within the
osteoblastic niche and a perturbation of a single element can cause
premature proplatelet extension and ineffective platelet release
into the blood stream.
Different cells, other than hOSTs, derive from hMSCs into the
bone marrow and support megakaryopoiesis [38]. Moreover, it
has been shown that hMSCs stimulate Mk and platelet production
from HSCs [39]. Thus, opposite signals are given to HSCs by
hMSCs and differentiated hOSTs. This work demonstrated that
hMSCs, and not hOSTs, constitutively express VCAM-1 [40],
and contribute to Mk development and PPF [41] by HSCs in co-
Figure 4. Involvement of type I collagen and VCAM-1 in
proplatelet formation. Megakaryocytes, differentiated in suspension
cultures for twelve days, were incubated for 30 min with unrelated
isotype-matched IgG (control), the monoclonal antibody anti-integrin
alpha2, clone P1E6, or anti-integrin alpha4, clone P1H4. Incubated cells,
as well as control cells, were allowed to adhere to hMSCs or hOSTs or
plated in suspension (control). (A) A reduction of about 30% in Mk
adhesion in the presence of the anti-alpha2 antibody on hOSTs was
observed, as shown in contrast phase images (scale bar =100 mm). (B)
The percentage of adherent megakaryocytes extending proplatelets
was evaluated after 16 hours. Significant difference in PPF is indicated
in comparison to Mks in adhesion to hMSCs or hOSTs without any
antibody pre-incubation. (C) Human megakaryocytes were treated with
100 mM blebbistatin or with DMSO for 30 min at 37uC prior to being
plated onto hOSTs. PPF was evaluated upon incubation for 16 h. Results
are reported as percentage proplatelet-forming cells compared with the
corresponding control sample (Mks in suspension), indicated by the
dotted line. Data are the mean 6 SD of the results obtained in three
different experiments for each sample. *p,0.05.
doi:10.1371/journal.pone.0008359.g004
Figure 5. Morphological analysis of proplatelets. Differential
interference contrast (DIC) and immunofluorescence (IF) images of a
megakaryocyte extending proplatelets in suspension (A), in adhesion to
hMSCs (B), or to hOSTs (C), as revealed by staining for CD61 (scale
bar =40 mm).
doi:10.1371/journal.pone.0008359.g005
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regulated VCAM-1 expression by hMSCs resulting in a more
limited effect on PPF that was comparable to the relative control.
These results could be explained by the existence of a possible
mechanism for inhibition of PPF in the less oxygenated areas that
are typical of the quiescent osteoblastic niche. By using a specific
antibody against integrin alpha4, the involvement of the VCAM-
1/VLA-4 axis in this regulatory mechanism was revealed, as
blocking of alpha4 suppressed the effect of hMSCs on PPF.
In conclusion, this study provides important new elements in the
understanding of the regulatory pathways for Mk maturation and
PPF within the bone marrow space. In particular, the development
of an in vitro model that combines the cellular, physical and
biochemical features of the osteoblastic niche to understand the
physiological mechanisms that regulate of megakaryopoiesis. In
future work, diseased cells may be incorporated into the model,
providing insight into the pathophysiology of defects of platelet
production as well as the ability to test the targets of new therapies
on normal and defective megakaryopoiesis [26,42].
Materials and Methods
Materials
Human mesenchymal stem cells (hMSCs) were from Clonetic-
Poietics (Walkersville, MD). Dulbecco’s modified Eagle’s medium
(DMEM), fetal bovine serum (FBS), penicillin-streptomycin, non-
essential amino acids and basic fibroblast growth factor (bFGF)
were from Gibco (Carlsbad, CA). Bovine purified type I collagen
was provided by Prof. Tira and Dr. Gruppi (University of Pavia).
Alizarin red solution (2%), blebbistatin, mouse anti-human type I
collagen and Poli-L-Lysine solution was from Sigma (St. Louis,
MO). Human umbilical cord blood was from The National
Disease Research Interchange (Philadelphia, PA). Lympholyte was
from Accurate Chemical and Scientific Corporation (New York,
NY). Immunomagnetic separation system was from Miltenyi
Biotech (Auburn, CA). Stem Span medium was from Stem-Cell
Technologies (Vancouver, Canada). Recombinant human TPO,
interleukin (IL)-6 and IL-11 were from PeproTech (Rocky Hill,
NJ). The following antibodies have been used: mouse monoclonal
anti-CD61, clone SZ21, from Immunotech (Marseille, France);
mouse anti-human integrin alpha2, clone P1E6, and anti-human
integrin alpha4, clone P1H4, from Chemicon International
(Billerica, MA), PE-conjugated mouse anti-human VCAM1 from
BD Pharmingen (San Diego, CA). Alexa Fluor 488-conjugated
chicken anti-mouse, Mowiol 4–88 and Hoechst 33258 were from
Molecular Probes (Eugene, OR). Oligonucleotide primers were
from Applied Biosystems (Foster City, CA). WesternBreeze
Chromogenic Western Blot Immunodetection Kit was from
Invitrogen (Carlsbad, CA).
hMSCs and Osteoblast culture
Human mesenchymal stem cells (hMSCs) were harvested and
cultured according to previously described protocols [41]. Briefly,
hMSCs were cultured in Dulbecco’s modified Eagle’s medium
(DMEM), supplemented with 10% fetal bovine serum, 100 U/mL
penicillin-streptomicin, 100 U/mL non-essential amminoacids, and
1 ng/mL basic fibroblast growth factor (bFGF) at 37uCi na5 %C O 2
fully-humidified atmosphere. To induce osteoblast differentiation,
h M S C sw e r ec u l t u r e di nD u l b e c c o ’ sm o d i f i e dE a g l e ’ sm e d i u m ,
supplemented with 10% fetal bovine serum, 100 U/mL penicillin-
streptomicin, 100 U/mL non-essential amminoacids, 100 nM Dexa-
methasone, 10 nM b-Glycerol phosphate and 0.05 mM Ascorbic acid
at 37uCi na5 %C O 2 fully-humidified atmosphere, either at 5% O2 or
20% O2. Cell culture medium was replenished every 2–3 days.
Total RNA extraction and real-time RT–PCR analysis
hMSCs and hOSTs were collected at different days of culture
and reverse transcription-polymerase chain reaction (RT-PCR)
analysis was performed. Total RNA was isolated using the RNeasy
mini kit (Qiagen, Valencia, CA) and reverse transcribed to cDNA
using SuperScript II reverse transcriptase (Invitrogen, Carlsbad,
CA) by following manufacturer’s instructions. For reverse
transcription, 5 ml of RNA sample with 45 ml of RNase-free water
was used to synthesize cDNA using a High-Capacity cDNA
Archive Kit (Applied Biosystem, Foster City, CA). Oligonucleotide
primers for type I collagen (Col I) and Alkaline Phosphatase (ALP)
and VCAM-1 transcripts were used in distinct PCR reactions
together with primers specific for the GAPDH gene, which was
selected as the housekeeping gene for determining relative
expression levels. All gene assays were pre-made and characterized
by Applied Biosystems following standard criteria. When bone
formation gene expression by hOSTs were analyzed, negative
controls were represented by hMSCs. In VCAM-1 RT-PCR
experiments hMSCs grown at 20% oxygen tension were
considered as standard reference. The PCR amplifications were
performed using ampli-Taq (Applied Biosystems, Foster City, CA)
and a programmable thermal controller Mx3000P QPCR system
(Stratagene, La Jolla, CA).
Dot-blot for type I collagen
hMSCs and hoSTS were washed with ice-cold PBS before
proteins were extracted in RIPA buffer (20 mMTris–HCl pH 7.4,
137 mM NaCl, 10% (v/v) glycerol, 1% (v/v) Triton X-100, 2 mM
EDTA) containing 0.5 mM protease inhibitor, phenylmethylsul-
phonylflouride (PMSF). After 30 min in ice, extracts were
centrifuged for 10 min at 10,0006g, 4uC, and the protein content
of the supernatants was determined by Bradford assay (Biorad).
10 mg of each sample including 40 ng of a positive control
(purified type I collagen) were applied directly to nitrocellulose
membranes. Membranes were blocked with 6% bovine serum
albumin (BSA) in Tris-buffered saline containing 0.05% Tween 20
at room temperature for 1 h and then incubated overnight at 4uC
with a primary monoclonal antibody against human Type I
collagen diluited 1:1000 and an alkaline phosphatase-conjugated
anti-mouse secondary antibody solution (WesternBreeze Chromo-
genic Western Blot Immunodetection kit). The blots were
developed and detected using the same Chromogenic detection
kit.
Calcium deposition assay
Calcium deposition was revealed by alizarin red assay at day 6,
11 and 18 of differentiation. Alizarin red solution (2%) was
prepared fresh and adjusted to pH 4.1–4.3. The cells were washed
with PBS, fixed with PFA 3% 15 min and deionized water before
2% alizarin red solution was added. The solution was removed
after 10 min and the cells were rinsed with deionized water.
Conventional microscopy was performed using a 10x objective
through an Axiovert S100 microscope with a Sony Exwave HAD
3CCD color video camera and the ImageJ acquisition software
(NIH).
Total collagen quantification
To assess the amount of collagen produced by the cells, the
amount of hydroxyproline was measured using a previously
described method [44]. The chloramine T solution and aldehyde-
perchloric acid solution used for the assay were prepared as
follows: Chloramine T (sodium N-chloro-p-toluenesulfonamide)
0.3535 g was dissolved in 5.175 mL of water, and then 6.5 mL of
In Vitro Megakaryopoiesis
PLoS ONE | www.plosone.org 7 December 2009 | Volume 4 | Issue 12 | e8359n-propanol and 13.325 mL of pH 6 buffer (citric acid monohy-
drate 25 g, acetic acid 6 mL, sodium acetate trihydrate 60 g,
sodium hydroxide 17 g to 500 mL) were added. Aldehyde-
perchloric acid solution was freshly made: 3.75 g of p-dimethyla-
minobenzaldehyde was dissolved in 15 mL of n-propanol, and
6.5 mL of perchloric acid was added slowly. First, the cells and
matrices were recovered from each well and hydrolyzed with 6 N
HCl at 115uC for 18 h on a heating block. The hydrolysate was
then transfered to eppendorf tubes and placed on a heating block
at 100uC overnight to allow acid to evaporate. The resultant
hydrolysate was dissolved in 3 mL water and evaporated at 95uC.
Finally, it was resuspended in 1.5 mL water and used as a sample.
A volume (250 mL) of chloramine T solution was added to 500 mL
of the sample and the mixture left for 20 min at room
temperature. Finally, 250 mL of p-dimethylaminobenzaldehyde
was added and the mixture incubated for 15 min at 60uC. After
cooling, the absorbance was read at 550 nm. Total hydroxyproline
concentration was then multiplied by a factor of 7.46 to give the
total collagen concentration as described in literature [45].
Second harmonic generation microscopy for analysis of
released type I collagen by osteoblasts
Second harmonic generation (SHG) micrographs were acquired
on a Leica DMIRE2 microscope with a TCS SP2 scanner
(Wetzlar, Germany). The excitation light source was a Mai Tai
tunable (710–920 nm) titanium sapphire laser emitting 100 fs
pulses at 80 MHz (Spectra Physics, Mountain View, CA).
Osteoblasts were placed onto 12 mm coverslips previously coated
with poli-L and excited at 800 nm. SHG images were acquired in
a transmission geometry through a filter centered at 400 nm
(Chroma hq400/20m-2p) with a 20-nm bandpass. Analysis was
performed with the Leica Confocal Software (Wetzlar, Germany)
and Image J (NIH, Bethesda, MD).
Flow cytometry analysis
hMSCs were collected using Trypsin 0.05% and washed with
PBS containing 50 mM EDTA and 0.5% fetal bovine serum and
then incubated with a PE-conjugated anti-VCAM1 antibody at
4uC for 30 minutes. After being washed twice with PBS, flow
cytometric analysis was performed. VCAM1 expression was
quantified using a FACSHCalibur flow cytometer (Becton Dick-
inson), with 50,000 events recorded for each sample. Experiments
were repeated at least twice under the same conditions and
settings.
Co-cultures experiments
Co-cultures with direct cell–cell contact were performed by
plating 7610
4 human umbilical cord blood CD34
+ cells directly
onto confluent layers of hMSCs or hOSTs at day 6 of
differentiation, in 24 well plates. Co-cultures were maintained
for up to 12 days as described below in the Mk differentiation
method. Controls were performed by seeding CD34
+ cells alone in
suspension cultures. Cultures were performed at either 5% O2 or
20% O2 for the entire experimental period. During co-culture the
amount of collagen released by hOSTs and its orientation through
second harmonic generation images were analyzed and compared
to hOSTs cultured alone at the same condition of co-cultures. Mk
and proplatelet formation were monitored as described below.
Differentiation of megakaryocytes from cord blood and
PPF evaluation
CD34
+ cells from human cord blood were separated as
previously described [46] and cultured in different co-culture
conditions for 12 days in Stem Span medium supplemented with
10 ng/mL TPO, IL-6, IL-11 at 37uCi na5 %C O 2 fully-
humidified atmosphere. Medium was changed at day 3, 7 and
10 of co-culture. At the end of co-culture, cell count to analyze
the output of HSCs in suspension and in adhesion to different
cell types was performed by phase-contrast microscopy. Briefly:
20 fields were taken randomly by phase-contrast microscopy
and the larger cells counted. To evaluate Mk yield a small
sample of suspension culture was cytospun onto glass coverslips,
while a hOST-HSC and a hMSC-HSC co-culture wells were
sacrificed upon staining with anti-CD61 antibody. Mks were
identified on the basis of CD61 expression, and assigned to
distinct stages of maturation according to the standard
morphological criteria [23]. Evaluation of Mks by phase
contrast and immunofluorescent microscopy resulted in com-
parable results.
The percentage of Mks extending proplatelets was evaluated
after 12 days of co-culture. Proplatelet-bearing Mks, in adhesion
to feeder layers in the direct co-culture or in suspension in the
indirect co-culture, were counted by differential interference
contrast (DIC) microscopy using a Leica DMIRE2 microscope
with a TCS SP2 scanner (Wetzlar, Germany) through a 63x
objective (1.2 NA). Afterwards, Mks extending proplatelet in the
indirect co-culture cultured were harvested, or previously gently
removed from the feeder layers when cultured in a direct cell-cell
contact, and cytospun onto glass coverslips before being stained
with the antibody against CD61 (see below). Mks forming
proplatelets were identified as large CD61
+ cells extending long
filamentous structures. The extent of PPF was calculated as the
percentage of proplatelet-bearing CD61
+ cells with respect to
total CD61
+ cells. Evaluation of PPF by phase contrast and
immunofluorescent microscopy resulted in perfectly comparable
results.
In some experiments, CD34
+ cells were cultured in
suspension for 12 days and 1610
5 mature Mks were then
pre-incubated for 30 minutes with 30 mg/mL mouse anti-
human integrin alpha2 or anti-human integrin alpha4, prior to
being plated. Negative controls were prepared with cells
incubated with identical concentrations of unrelated isotype-
matched IgG.
Immunofluorescence analysis
Mks were cytospun onto glass coverslips and fixed in 3%
paraformaldehyde for 20 minutes at RT. Upon washing with PBS,
cells were blocked with 3% BSA in PBS for 1 hour at RT. Cells
were then incubated for 1 hour at RT with the primary
monoclonal antibody mouse anti-CD61, clone SZ21, 1:100,
diluted in PBS. After washing with PBS, cells were incubated
with 10 mg/mL of the secondary antibody conjugated with Alexa
Fluor 488 in PBS for 1 hour at RT. Specimens were mounted in
Mowiol 4–88. Images were acquired using a Leica DMIRE2
microscope with a TCS SP2 scanner (Wetzlar, Germany) through
a 63x objective (1.2 NA). For each specimen, at least 100 Mks were
evaluated.
Statistics
Values were expressed as mean 6 SD (standard deviation).
Analysis by one-way ANOVA was followed by post-hoc testing
(Bonferroni’s t-test). Student t-test was performed for paired
observations. A value of p,0.05 was considered statistically
significant. Statistical analysis was carried out using SigmaStat
3.0 software. All experiments were independently replicated at
least three times.
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